Igarashi, Masaki
Naruse, Kyoko
Takaoka, Yuriko
Miura, Masaomi
Kashiwabara, Kosuke
Sawada, Mika
Sekine, Rie
Kubota, Naoto
Suzuki, Motoo
Yoshida, Yuki
Shimizu, Noriaki
Yaku, Keisuke
Nakagawa, Takashi
Yamauchi, Toshimasa
Funding for this research was provided by:
MIRAILAB BIOSCIENCE Inc.
Article History
Received: 2 March 2026
Accepted: 10 August 2026
First Online: 25 September 2026
Declarations
Competing interests: The Authors M.S., Y.Y., and N.Sh. declare financial competing interests as employees of MIRAILAB BIOSCIENCE Inc. N.S. also serves as the CEO, CTO, and Representative Director of MIRAILAB BIOSCIENCE Inc. MIRAILAB BIOSCIENCE Inc. provided the NMN used in this study and technical support for ELISA-based biomarker measurements. The company was not involved in the study design, clinical data collection, statistical analysis, interpretation of the data, preparation of the manuscript, or the decision to submit the manuscript for publication. The other authors declare no competing interests.